Therapy Areas: Oncology
Sling Therapeutics names new chairman of the board of directors
28 June 2022 -

Sling Therapeutics, Inc., a US-based biopharmaceutical company, announced on Monday that it has named Faheem Hasnain as its new chairman of the company's board of directors.

Hasnain has served as the founder, chief executive officer, and chairman of Gossamer Bio. He also holds the position of the lead independent director for Kura Oncology and is chairman of the board of directors for Aspen Neuroscience, Mirati Therapeutics and SENTÉ. He is the former president and chief executive officer of Receptos, Facet Biotech and PDL BioPharma.

Hasnain has a BHK and a BEd from the University of Windsor.



Related Headlines